Zhinan Xia

Zhinan Xia

Zhinan Xia

Chief Scientific Officer

Biography

Dr. Xia has more than 30 years of experience in the research and development of therapeutic antibodies, from early validation through pre-clinical development. His previous positions include Head of Biotherapeutics at Moderna, where he focused on the discovery of immuno-oncology, autoimmune, and infectious disease therapeutics, Director at Synageva BioPharma, where he was responsible for early biologics discovery in rare and orphan diseases, and Pfizer, where he served in a variety of scientific roles, leading teams in immuno-oncology target identification and validation and bi- and multi-specific antibody design and development.

He has also served as an Instructor at Dana Farber Cancer Institute and Harvard Medical School, having completed a post-doctoral fellowship in immunology at Harvard Medical School following receipt of his PhD in Immunology and Molecular Biology from the University of Kentucky. His efforts have been recognized globally, receiving the NIH National Research Service Award in 1994, an AAPS award (New York) in 2001, and having been named an Outstanding Alumnus of China Pharmaceutical University in 2016.

back to top

Call For Abstracts


    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.